Global Breast Cancer Liquid Biopsy Market Insights, Forecast to 2025

Publisher Name :
Date: 14-May-2019
No. of pages: 112
Inquire Before Buying

Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.

The global Breast Cancer Liquid Biopsy market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Breast Cancer Liquid Biopsy market based on company, product type, end user and key regions.

This report studies the global market size of Breast Cancer Liquid Biopsy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Breast Cancer Liquid Biopsy in these regions.

This research report categorizes the global Breast Cancer Liquid Biopsy market by top players/brands, region, type and end user. This report also studies the global Breast Cancer Liquid Biopsy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- QIAGEN

- Roche Diagnostics

- Bio-Rad Laboratories

- Myriad Genetics

- Menarini Silicon Biosystems

- Genomic Health

- Thermo Fisher Scientific

- Illumina

- Biocept

- Trovagene

- Guardant Health

- RainDance Technologies

- MDx Health

Market size by Product

- Circulating Tumor Cells (CTCs)

- Cell-Free DNA (CfDNA)

- Extracellular Vesicles (EVs)

- Other Circulating Biomarkers

Market size by End User

- Hospitals

- Diagnostic Centers

- Laboratories

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Breast Cancer Liquid Biopsy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Breast Cancer Liquid Biopsy market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Breast Cancer Liquid Biopsy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Breast Cancer Liquid Biopsy submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Breast Cancer Liquid Biopsy are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Breast Cancer Liquid Biopsy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Breast Cancer Liquid Biopsy Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Breast Cancer Liquid Biopsy Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Product
1.4.2 Circulating Tumor Cells (CTCs)
1.4.3 Cell-Free DNA (CfDNA)
1.4.4 Extracellular Vesicles (EVs)
1.4.5 Other Circulating Biomarkers
1.5 Market by End User
1.5.1 Global Breast Cancer Liquid Biopsy Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Diagnostic Centers
1.5.4 Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Breast Cancer Liquid Biopsy Market Size
2.1.1 Global Breast Cancer Liquid Biopsy Revenue 2014-2025
2.1.2 Global Breast Cancer Liquid Biopsy Sales 2014-2025
2.2 Breast Cancer Liquid Biopsy Growth Rate by Regions
2.2.1 Global Breast Cancer Liquid Biopsy Sales by Regions
2.2.2 Global Breast Cancer Liquid Biopsy Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Breast Cancer Liquid Biopsy Sales by Manufacturers
3.1.1 Breast Cancer Liquid Biopsy Sales by Manufacturers
3.1.2 Breast Cancer Liquid Biopsy Sales Market Share by Manufacturers
3.1.3 Global Breast Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.2 Breast Cancer Liquid Biopsy Revenue by Manufacturers
3.2.1 Breast Cancer Liquid Biopsy Revenue by Manufacturers (2014-2019)
3.2.2 Breast Cancer Liquid Biopsy Revenue Share by Manufacturers (2014-2019)
3.3 Breast Cancer Liquid Biopsy Price by Manufacturers
3.4 Breast Cancer Liquid Biopsy Manufacturing Base Distribution, Product Types
3.4.1 Breast Cancer Liquid Biopsy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Breast Cancer Liquid Biopsy Product Type
3.4.3 Date of International Manufacturers Enter into Breast Cancer Liquid Biopsy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Breast Cancer Liquid Biopsy Sales by Product
4.2 Global Breast Cancer Liquid Biopsy Revenue by Product
4.3 Breast Cancer Liquid Biopsy Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Breast Cancer Liquid Biopsy Breakdown Data by End User
6 North America
6.1 North America Breast Cancer Liquid Biopsy by Countries
6.1.1 North America Breast Cancer Liquid Biopsy Sales by Countries
6.1.2 North America Breast Cancer Liquid Biopsy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Breast Cancer Liquid Biopsy by Product
6.3 North America Breast Cancer Liquid Biopsy by End User
7 Europe
7.1 Europe Breast Cancer Liquid Biopsy by Countries
7.1.1 Europe Breast Cancer Liquid Biopsy Sales by Countries
7.1.2 Europe Breast Cancer Liquid Biopsy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Breast Cancer Liquid Biopsy by Product
7.3 Europe Breast Cancer Liquid Biopsy by End User
8 Asia Pacific
8.1 Asia Pacific Breast Cancer Liquid Biopsy by Countries
8.1.1 Asia Pacific Breast Cancer Liquid Biopsy Sales by Countries
8.1.2 Asia Pacific Breast Cancer Liquid Biopsy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Breast Cancer Liquid Biopsy by Product
8.3 Asia Pacific Breast Cancer Liquid Biopsy by End User
9 Central & South America
9.1 Central & South America Breast Cancer Liquid Biopsy by Countries
9.1.1 Central & South America Breast Cancer Liquid Biopsy Sales by Countries
9.1.2 Central & South America Breast Cancer Liquid Biopsy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Breast Cancer Liquid Biopsy by Product
9.3 Central & South America Breast Cancer Liquid Biopsy by End User
10 Middle East and Africa
10.1 Middle East and Africa Breast Cancer Liquid Biopsy by Countries
10.1.1 Middle East and Africa Breast Cancer Liquid Biopsy Sales by Countries
10.1.2 Middle East and Africa Breast Cancer Liquid Biopsy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Breast Cancer Liquid Biopsy by Product
10.3 Middle East and Africa Breast Cancer Liquid Biopsy by End User
11 Company Profiles
11.1 QIAGEN
11.1.1 QIAGEN Company Details
11.1.2 Company Business Overview
11.1.3 QIAGEN Breast Cancer Liquid Biopsy Sales, Revenue and Gross Margin (2014-2019)
11.1.4 QIAGEN Breast Cancer Liquid Biopsy Products Offered
11.1.5 QIAGEN Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Details
11.2.2 Company Business Overview
11.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Roche Diagnostics Breast Cancer Liquid Biopsy Products Offered
11.2.5 Roche Diagnostics Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Company Business Overview
11.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Products Offered
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Details
11.4.2 Company Business Overview
11.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Myriad Genetics Breast Cancer Liquid Biopsy Products Offered
11.4.5 Myriad Genetics Recent Development
11.5 Menarini Silicon Biosystems
11.5.1 Menarini Silicon Biosystems Company Details
11.5.2 Company Business Overview
11.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Products Offered
11.5.5 Menarini Silicon Biosystems Recent Development
11.6 Genomic Health
11.6.1 Genomic Health Company Details
11.6.2 Company Business Overview
11.6.3 Genomic Health Breast Cancer Liquid Biopsy Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Genomic Health Breast Cancer Liquid Biopsy Products Offered
11.6.5 Genomic Health Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Company Business Overview
11.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Products Offered
11.7.5 Thermo Fisher Scientific Recent Development
11.8 Illumina
11.8.1 Illumina Company Details
11.8.2 Company Business Overview
11.8.3 Illumina Breast Cancer Liquid Biopsy Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Illumina Breast Cancer Liquid Biopsy Products Offered
11.8.5 Illumina Recent Development
11.9 Biocept
11.9.1 Biocept Company Details
11.9.2 Company Business Overview
11.9.3 Biocept Breast Cancer Liquid Biopsy Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Biocept Breast Cancer Liquid Biopsy Products Offered
11.9.5 Biocept Recent Development
11.10 Trovagene
11.10.1 Trovagene Company Details
11.10.2 Company Business Overview
11.10.3 Trovagene Breast Cancer Liquid Biopsy Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Trovagene Breast Cancer Liquid Biopsy Products Offered
11.10.5 Trovagene Recent Development
11.11 Guardant Health
11.12 RainDance Technologies
11.13 MDx Health
12 Future Forecast
12.1 Breast Cancer Liquid Biopsy Market Forecast by Regions
12.1.1 Global Breast Cancer Liquid Biopsy Sales Forecast by Regions 2019-2025
12.1.2 Global Breast Cancer Liquid Biopsy Revenue Forecast by Regions 2019-2025
12.2 Breast Cancer Liquid Biopsy Market Forecast by Product
12.2.1 Global Breast Cancer Liquid Biopsy Sales Forecast by Product 2019-2025
12.2.2 Global Breast Cancer Liquid Biopsy Revenue Forecast by Product 2019-2025
12.3 Breast Cancer Liquid Biopsy Market Forecast by End User
12.4 North America Breast Cancer Liquid Biopsy Forecast
12.5 Europe Breast Cancer Liquid Biopsy Forecast
12.6 Asia Pacific Breast Cancer Liquid Biopsy Forecast
12.7 Central & South America Breast Cancer Liquid Biopsy Forecast
12.8 Middle East and Africa Breast Cancer Liquid Biopsy Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Breast Cancer Liquid Biopsy Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Breast Cancer Liquid Biopsy Product Picture
Table Breast Cancer Liquid Biopsy Market Segments
Table Key Manufacturers Breast Cancer Liquid Biopsy Covered
Table Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Breast Cancer Liquid Biopsy Sales Market Share by Product 2014-2025
Figure Circulating Tumor Cells (CTCs) Product Picture
Table Major Manufacturers of Circulating Tumor Cells (CTCs)
Figure Cell-Free DNA (CfDNA) Product Picture
Table Major Manufacturers of Cell-Free DNA (CfDNA)
Figure Extracellular Vesicles (EVs) Product Picture
Table Major Manufacturers of Extracellular Vesicles (EVs)
Figure Other Circulating Biomarkers Product Picture
Table Major Manufacturers of Other Circulating Biomarkers
Table Global Breast Cancer Liquid Biopsy Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Diagnostic Centers
Figure Laboratories
Figure Breast Cancer Liquid Biopsy Report Years Considered
Figure Global Breast Cancer Liquid Biopsy Market Size 2014-2025 (Million US$)
Figure Global Breast Cancer Liquid Biopsy Sales 2014-2025 (K Units)
Table Global Breast Cancer Liquid Biopsy Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Breast Cancer Liquid Biopsy Sales by Regions 2014-2019 (K Units)
Table Global Breast Cancer Liquid Biopsy Sales Market Share by Regions 2014-2019
Figure Global Breast Cancer Liquid Biopsy Sales Market Share by Regions 2014-2019
Figure 2018 Global Breast Cancer Liquid Biopsy Sales Market Share by Regions
Table Global Breast Cancer Liquid Biopsy Revenue by Regions 2014-2019 (Million US$)
Table Global Breast Cancer Liquid Biopsy Revenue Market Share by Regions 2014-2019
Figure Global Breast Cancer Liquid Biopsy Revenue Market Share by Regions 2014-2019
Figure 2018 Global Breast Cancer Liquid Biopsy Revenue Market Share by Regions
Table Global Breast Cancer Liquid Biopsy Sales by Manufacturers (2014-2019) (K Units)
Table Global Breast Cancer Liquid Biopsy Sales Share by Manufacturers (2014-2019)
Figure Global Breast Cancer Liquid Biopsy Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Breast Cancer Liquid Biopsy Revenue by Manufacturers (2014-2019) (Million USD)
Table Breast Cancer Liquid Biopsy Revenue Share by Manufacturers (2014-2019)
Figure Breast Cancer Liquid Biopsy Value Share by Manufacturers in 2018
Table Key Manufacturers Breast Cancer Liquid Biopsy Price (2014-2019) (USD/Unit)
Table Breast Cancer Liquid Biopsy Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Breast Cancer Liquid Biopsy Product Type
Table Date of International Manufacturers Enter into Breast Cancer Liquid Biopsy Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Breast Cancer Liquid Biopsy Sales by Product (2014-2019) (K Units)
Table Global Breast Cancer Liquid Biopsy Sales Share by Product (2014-2019)
Figure Global Breast Cancer Liquid Biopsy Sales Market Share by Product (2014-2019)
Figure Global Breast Cancer Liquid Biopsy Sales Market Share by Product in 2018
Table Global Breast Cancer Liquid Biopsy Revenue by Product (2014-2019) (Million US$)
Table Global Breast Cancer Liquid Biopsy Revenue Share by Product (2014-2019)
Figure Global Breast Cancer Liquid Biopsy Revenue Market Share by Product (2014-2019)
Figure Global Breast Cancer Liquid Biopsy Revenue Market Share by Product in 2018
Table Breast Cancer Liquid Biopsy Price by Product 2014-2019 (USD/Unit)
Table Global Breast Cancer Liquid Biopsy Sales by End User (2014-2019) (K Units)
Table Global Breast Cancer Liquid Biopsy Sales Share by End User (2014-2019)
Figure Global Sales Breast Cancer Liquid Biopsy Market Share by End User (2014-2019)
Figure Global Sales Breast Cancer Liquid Biopsy Market Share by End User in 2018
Figure North America Breast Cancer Liquid Biopsy Sales Growth Rate 2014-2019 (K Units)
Figure North America Breast Cancer Liquid Biopsy Revenue Growth Rate 2014-2019 (Million US$)
Table North America Breast Cancer Liquid Biopsy Sales by Countries (2014-2019) (K Units)
Table North America Breast Cancer Liquid Biopsy Sales Market Share by Countries (2014-2019)
Figure 2018 North America Breast Cancer Liquid Biopsy Sales Market Share by Countries
Table North America Breast Cancer Liquid Biopsy Revenue by Countries (2014-2019) (Million US$)
Table North America Breast Cancer Liquid Biopsy Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Breast Cancer Liquid Biopsy Revenue Market Share by Countries
Figure United States Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure United States Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Canada Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Table North America Breast Cancer Liquid Biopsy Sales by Product (2014-2019) (K Units)
Table North America Breast Cancer Liquid Biopsy Sales Market Share by Product (2014-2019)
Figure 2018 North America Breast Cancer Liquid Biopsy Market Share by Product
Table North America Breast Cancer Liquid Biopsy Sales by End User (2014-2019) (K Units)
Table North America Breast Cancer Liquid Biopsy Sales Market Share by End User (2014-2019)
Figure 2018 North America Breast Cancer Liquid Biopsy Market Share by End User
Figure Europe Breast Cancer Liquid Biopsy Sales Growth Rate 2014-2019 (K Units)
Figure Europe Breast Cancer Liquid Biopsy Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Breast Cancer Liquid Biopsy Sales by Countries (2014-2019) (K Units)
Table Europe Breast Cancer Liquid Biopsy Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Breast Cancer Liquid Biopsy Sales Market Share by Countries
Table Europe Breast Cancer Liquid Biopsy Revenue by Countries (2014-2019) (Million US$)
Table Europe Breast Cancer Liquid Biopsy Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Breast Cancer Liquid Biopsy Revenue Market Share by Countries
Figure Germany Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Germany Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure France Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure France Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure UK Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Italy Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Russia Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Breast Cancer Liquid Biopsy Sales by Product (2014-2019) (K Units)
Table Europe Breast Cancer Liquid Biopsy Sales Market Share by Product (2014-2019)
Figure 2018 Europe Breast Cancer Liquid Biopsy Market Share by Product
Table Europe Breast Cancer Liquid Biopsy Sales by End User (2014-2019) (K Units)
Table Europe Breast Cancer Liquid Biopsy Sales Market Share by End User (2014-2019)
Figure 2018 Europe Breast Cancer Liquid Biopsy Market Share by End User
Figure Asia Pacific Breast Cancer Liquid Biopsy Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Breast Cancer Liquid Biopsy Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Breast Cancer Liquid Biopsy Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Breast Cancer Liquid Biopsy Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Breast Cancer Liquid Biopsy Sales Market Share by Countries
Table Asia Pacific Breast Cancer Liquid Biopsy Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Breast Cancer Liquid Biopsy Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Breast Cancer Liquid Biopsy Revenue Market Share by Countries
Figure China Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure China Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Japan Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Korea Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure India Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure India Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Australia Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Breast Cancer Liquid Biopsy Sales by Product (2014-2019) (K Units)
Table Asia Pacific Breast Cancer Liquid Biopsy Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Breast Cancer Liquid Biopsy Market Share by Product
Table Asia Pacific Breast Cancer Liquid Biopsy Sales by End User (2014-2019) (K Units)
Table Asia Pacific Breast Cancer Liquid Biopsy Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Breast Cancer Liquid Biopsy Market Share by End User
Figure Central & South America Breast Cancer Liquid Biopsy Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Breast Cancer Liquid Biopsy Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Breast Cancer Liquid Biopsy Sales by Countries (2014-2019) (K Units)
Table Central & South America Breast Cancer Liquid Biopsy Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Breast Cancer Liquid Biopsy Sales Market Share by Countries
Table Central & South America Breast Cancer Liquid Biopsy Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Breast Cancer Liquid Biopsy Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Breast Cancer Liquid Biopsy Revenue Market Share by Countries
Figure Brazil Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Breast Cancer Liquid Biopsy Sales by Product (2014-2019) (K Units)
Table Central & South America Breast Cancer Liquid Biopsy Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Breast Cancer Liquid Biopsy Market Share by Product
Table Central & South America Breast Cancer Liquid Biopsy Sales by End User (2014-2019) (K Units)
Table Central & South America Breast Cancer Liquid Biopsy Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Breast Cancer Liquid Biopsy Market Share by End User
Figure Middle East and Africa Breast Cancer Liquid Biopsy Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Breast Cancer Liquid Biopsy Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Breast Cancer Liquid Biopsy Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Breast Cancer Liquid Biopsy Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Breast Cancer Liquid Biopsy Sales Market Share by Countries
Table Middle East and Africa Breast Cancer Liquid Biopsy Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Breast Cancer Liquid Biopsy Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Breast Cancer Liquid Biopsy Revenue Market Share by Countries
Figure GCC Countries Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Breast Cancer Liquid Biopsy Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Breast Cancer Liquid Biopsy Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Breast Cancer Liquid Biopsy Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Breast Cancer Liquid Biopsy Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Breast Cancer Liquid Biopsy Market Share by Product
Table Middle East and Africa Breast Cancer Liquid Biopsy Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Breast Cancer Liquid Biopsy Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Breast Cancer Liquid Biopsy Market Share by End User
Table QIAGEN Company Details
Table QIAGEN Breast Cancer Liquid Biopsy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table QIAGEN Recent Development
Table Roche Diagnostics Company Details
Table Roche Diagnostics Breast Cancer Liquid Biopsy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Diagnostics Recent Development
Table Bio-Rad Laboratories Company Details
Table Bio-Rad Laboratories Breast Cancer Liquid Biopsy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bio-Rad Laboratories Recent Development
Table Myriad Genetics Company Details
Table Myriad Genetics Breast Cancer Liquid Biopsy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Myriad Genetics Recent Development
Table Menarini Silicon Biosystems Company Details
Table Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Menarini Silicon Biosystems Recent Development
Table Genomic Health Company Details
Table Genomic Health Breast Cancer Liquid Biopsy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Genomic Health Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Breast Cancer Liquid Biopsy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Thermo Fisher Scientific Recent Development
Table Illumina Company Details
Table Illumina Breast Cancer Liquid Biopsy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Illumina Recent Development
Table Biocept Company Details
Table Biocept Breast Cancer Liquid Biopsy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biocept Recent Development
Table Trovagene Company Details
Table Trovagene Breast Cancer Liquid Biopsy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Trovagene Recent Development
Table Guardant Health Company Details
Table RainDance Technologies Company Details
Table MDx Health Company Details
Table Global Breast Cancer Liquid Biopsy Sales Forecast by Regions 2019-2025 (K Units)
Table Global Breast Cancer Liquid Biopsy Sales Market Share Forecast by Regions 2019-2025
Table Global Breast Cancer Liquid Biopsy Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Breast Cancer Liquid Biopsy Revenue Market Share Forecast by Regions 2019-2025
Table Global Breast Cancer Liquid Biopsy Sales Forecast by Product 2019-2025 (K Units)
Table Global Breast Cancer Liquid Biopsy Sales Market Share Forecast by Product 2019-2025
Table Global Breast Cancer Liquid Biopsy Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Breast Cancer Liquid Biopsy Revenue Market Share Forecast by Product 2019-2025
Table Global Breast Cancer Liquid Biopsy Sales Forecast by End User 2019-2025 (K Units)
Table Global Breast Cancer Liquid Biopsy Sales Market Share Forecast by End User 2019-2025
Figure North America Breast Cancer Liquid Biopsy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Breast Cancer Liquid Biopsy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Breast Cancer Liquid Biopsy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Breast Cancer Liquid Biopsy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Breast Cancer Liquid Biopsy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Breast Cancer Liquid Biopsy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Breast Cancer Liquid Biopsy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Breast Cancer Liquid Biopsy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Breast Cancer Liquid Biopsy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Breast Cancer Liquid Biopsy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Breast Cancer Liquid Biopsy Value Chain
Table Breast Cancer Liquid Biopsy Customers List
Table Breast Cancer Liquid Biopsy Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs